Showing results (441-450 of 772) with videos related to

Sort By:
Pageof 78
The Journal of Antimicrobial Chemotherapy|March 27, 2020
Impact of first-line antiretroviral therapy regimens on the restoration of the CD4/CD8 ratio in the CNICS cohortSabina Herrera, Borja M Fernandez-Felix, Peter W Hunt, et al.
Plos Pathogens|March 6, 2018
A20 upregulation during treated HIV disease is associated with intestinal epithelial cell recovery and functionAvantika S Chitre, Michael G Kattah, Yenny Y Rosli, et al.
Cell Host & Microbe|May 12, 2017
SMYD2-Mediated Histone Methylation Contributes to HIV-1 LatencyDaniela Boehm, Mark Jeng, Gregory Camus, et al.
The Journal of Infectious Diseases|November 3, 2019
Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment InterruptionCecilia A Prator, Cassandra Thanh, Shreya Kumar, et al.
Nature Communications|February 20, 2019
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4+ T cells from ART-suppressed individualsRémi Fromentin, Sandrina DaFonseca, Cecilia T Costiniuk, et al.
The Journal of Infectious Diseases|June 18, 2014
Decreased HIV type 1 transcription in CCR5-Δ32 heterozygotes during suppressive antiretroviral therapyCharlene Wang, Mohamed Abdel-Mohsen, Matthew C Strain, et al.
Nature Microbiology|January 30, 2023
Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virusLaura P Kincer, Sarah Beth Joseph, Maria M Gilleece, et al.
Annals of Neurology|March 14, 2022
SARS-CoV-2 and Mitochondrial Proteins in Neural-Derived Exosomes of COVID-19Michael J Peluso, Steven G Deeks, Maja Mustapic, et al.
Frontiers in Immunology|August 8, 2022
Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV gag conserved elements in macaquesAntonio Valentin, Cristina Bergamaschi, Margherita Rosati, et al.
Pageof 78